Sep 19, 2018   SOURCE: PR NewsWire

Wilson's Disease Epiomic Epidemiology Forecast 2018-2028

DUBLIN, Sept. 19, 2018 /PRNewswire/ --

The "Epiomic Epidemiology Series: Wilson's Disease Forecast In 28 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Wilson's disease, also known as progressive lenticular degeneration, is a genetic disorder inherited in an autosomal recessive manner. It is caused by mutations in a gene coding for a copper-transporting protein with a key role in copper metabolism. Reduced activity of the protein leads to copper accumulation in the body which results in various hepatic, osseous, neurological and psychiatric manifestations. Although the genotype-phenotype correlation is still to be elucidated, therapies that are currently available permit patients to live fairly normal lives. However, hepatic and neurological damage sustained prior to the commencement of therapy can be irreversible.

This report provides the current prevalent population for Wilson's disease across 28 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Belgium, Norway, Sweden, Denmark, Finland, Austria, Switzerland, Ireland, Bulgaria, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the publisher's analysis team, Wilson's disease patients grouped by genetic features, various symptoms and treatments have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities of Wilson's disease include:

    --  Hepatitis and liver cirrhosis
    --  Affective disorders
    --  Back pain and stiffness
    --  Osteoporosis and frequent bone fractures
    --  Amenorrhoea

    --  Fertility problems

Key Topics Covered: 

    1. List Of Tables And Figures
    2. Introduction
    3. Cause Of The Disease
    4. Risk Factors & Prevention
    5. Diagnosis Of The Disease
    6. Variation By Geography/Ethnicity
    7. Disease Prognosis & Clinical Course
    8. Key Comorbid Conditions / Features Associated With The Disease
    9. Methodology For Quantification Of Patient Numbers
    10. Top-Line Prevalence For Wilson'S Disease
    11. Features Of Wilson'S Disease Patients
    12. Signs And Symptoms Of Wilson'S Disease Patients
    13. Hepatic Signs And Symptoms
    14. Neurological Signs And Symptoms
    15. Psychological Signs And Symptoms
    16. Ophthalmologic Signs And Symptoms
    17. Treatment Of Wilson'S Disease Patients
    18. Abbreviations Used In The Report
    19. Other Publisher Services & Solutions
    20. Reports & Publications
    21. Online Epidemiology Databases
    22. Online Pharmaceutical Pricing Database
    23. References

    24. Appendix

For more information about this report visit

https://www.researchandmarkets.com/research/8phsm2/wilsons_disease?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/wilsons-disease-epiomic-epidemiology-forecast-2018-2028-300715443.html

SOURCE Research and Markets